A University of Chicago researcher who has developed a new treatment for migraines has raised $750,000 for his startup.
Seurat Therapeutics treats migraines with a nasal spray of an insulin-like hormone called growth factor 1.
from nicholemhearn digest http://www.chicagobusiness.com/article/20180330/BLOGS11/180339989/u-of-c-startup-that-targets-migraines-gets-seed-money?utm_source=BLOGS11&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment